Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Mills

Showing results (1001-1010 of 1,298) with videos related to

Pageof 130
Sort By:
Cell Reports|September 14, 2022
BET inhibition induces vulnerability to MCL1 targeting through upregulation of fatty acid synthesis pathway in breast cancerGonghong Yan, Augustin Luna, Heping Wang, et al.
Nature Medicine|June 3, 2000
Efficient retrovirus-mediated transfer of the multidrug resistance 1 gene into autologous human long-term repopulating hematopoietic stem cellsR Abonour, D A Williams, L Einhorn, et al.
Molecular Cancer Therapeutics|March 31, 2019
Prospective Clinical Sequencing of Adult GliomaSiyuan Zheng, Kristin Alfaro-Munoz, Wei Wei, et al.
Biomedical Optics Express|January 20, 2017
Endoscopic sensing of alveolar pHD Choudhury, M G Tanner, S McAughtrie, et al.
Leukemia|May 19, 2022
PU.1 and MYC transcriptional network defines synergistic drug responses to KIT and LSD1 inhibition in acute myeloid leukemiaBrittany M Curtiss, Jake VanCampen, Jommel Macaraeg, et al.
NPJ Systems Biology and Applications|July 21, 2017
Genome-wide perturbations by miRNAs map onto functional cellular pathways, identifying regulators of chromatin modifiersTyler J Moss, Zijun Luo, Elena G Seviour, et al.
Cell Systems|March 12, 2018
The Genomic Landscape and Pharmacogenomic Interactions of Clock Genes in Cancer ChronotherapyYouqiong Ye, Yu Xiang, Fatma Muge Ozguc, et al.
Cancer Research|May 6, 2017
Oncogenic RAS Regulates Long Noncoding RNA <i>Orilnc1</i> in Human CancerDongmei Zhang, Gao Zhang, Xiaowen Hu, et al.
Molecular Cell|April 21, 2018
EGFR-Phosphorylated Platelet Isoform of Phosphofructokinase 1 Promotes PI3K ActivationJong-Ho Lee, Rui Liu, Jing Li, et al.
Oncogene|January 29, 2014
Elafin drives poor outcome in high-grade serous ovarian cancers and basal-like breast tumorsS I Labidi-Galy, A Clauss, V Ng, et al.
Pageof 130

Showing results (1001-1010 of 1,298) with videos related to

Sort By:
Pageof 130
Cell Reports|September 14, 2022
BET inhibition induces vulnerability to MCL1 targeting through upregulation of fatty acid synthesis pathway in breast cancerGonghong Yan, Augustin Luna, Heping Wang, et al.
Nature Medicine|June 3, 2000
Efficient retrovirus-mediated transfer of the multidrug resistance 1 gene into autologous human long-term repopulating hematopoietic stem cellsR Abonour, D A Williams, L Einhorn, et al.
Molecular Cancer Therapeutics|March 31, 2019
Prospective Clinical Sequencing of Adult GliomaSiyuan Zheng, Kristin Alfaro-Munoz, Wei Wei, et al.
Biomedical Optics Express|January 20, 2017
Endoscopic sensing of alveolar pHD Choudhury, M G Tanner, S McAughtrie, et al.
Leukemia|May 19, 2022
PU.1 and MYC transcriptional network defines synergistic drug responses to KIT and LSD1 inhibition in acute myeloid leukemiaBrittany M Curtiss, Jake VanCampen, Jommel Macaraeg, et al.
NPJ Systems Biology and Applications|July 21, 2017
Genome-wide perturbations by miRNAs map onto functional cellular pathways, identifying regulators of chromatin modifiersTyler J Moss, Zijun Luo, Elena G Seviour, et al.
Cell Systems|March 12, 2018
The Genomic Landscape and Pharmacogenomic Interactions of Clock Genes in Cancer ChronotherapyYouqiong Ye, Yu Xiang, Fatma Muge Ozguc, et al.
Cancer Research|May 6, 2017
Oncogenic RAS Regulates Long Noncoding RNA <i>Orilnc1</i> in Human CancerDongmei Zhang, Gao Zhang, Xiaowen Hu, et al.
Molecular Cell|April 21, 2018
EGFR-Phosphorylated Platelet Isoform of Phosphofructokinase 1 Promotes PI3K ActivationJong-Ho Lee, Rui Liu, Jing Li, et al.
Oncogene|January 29, 2014
Elafin drives poor outcome in high-grade serous ovarian cancers and basal-like breast tumorsS I Labidi-Galy, A Clauss, V Ng, et al.
Pageof 130